Prestige Wealth Management Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-44
Closed -$3.27K 1103
2022
Q4
$3.27K Buy
+44
New +$3K ﹤0.01% 724
2021
Q1
Sell
-5
Closed 981
2020
Q4
$0 Buy
+5
New +$287 ﹤0.01% 973

Other funds holding GMED

Prestige Wealth Management Group's GMED Position: Q1 2023 in Review

Prestige Wealth Management Group sold out of Globus Medical (GMED) in Q1 2023, closing a stake of 44 shares — an estimated $3.27K sold.

Prestige Wealth Management Group first reported a position in GMED in Q4 2020 and held it in 2 quarters. The position peaked at $3.27K in Q4 2022. 390 funds tracked by Wall St. Rank hold GMED as of Q1 2023.

  • Prestige Wealth Management Group reported no remaining Globus Medical position as of Q1 2023 after selling out during the quarter.
  • Prestige Wealth Management Group sold 44 Globus Medical shares in Q1 2023, an estimated $3.27K.
  • Prestige Wealth Management Group first reported a position in Globus Medical in Q4 2020 and held it in 2 quarters.
  • Prestige Wealth Management Group's Globus Medical position peaked at $3.27K in Q4 2022.
  • 390 funds tracked by Wall St. Rank held Globus Medical as of Q1 2023.

Based on Prestige Wealth Management Group's 13F filing for Q1 2023, filed 16 May 2023.